Lateral Flow Assay Market Report by Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), Product (Kits and Reagents, Lateral Flow Readers), Application (Clinical Testing, Veterinary Diagnostics, Food Safety and Environment Testing,

Lateral Flow Assay Market Report by Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), Product (Kits and Reagents, Lateral Flow Readers), Application (Clinical Testing, Veterinary Diagnostics, Food Safety and Environment Testing, Drug Development and Quality Testing), End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care, Pharmaceutical and Biotechnology Companies, and Others), and Region 2023-2028

The global lateral flow assay market size reached US$ 9.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.22% during 2022-2028.

Lateral flow assay (LFA) is a paper-based platform that detects and quantifies analytes in complex mixtures. It assists in testing biological samples of saliva, urine, sweat, serum, plasma, blood, and other fluids. As a result, it is widely employed in hospitals and clinical laboratories for the qualitative and quantitative detection of specific agents, antibodies, and gene amplification. Besides this, as it also aids in producing low-cost, simple, rapid, and portable detection devices that are utilized in biomedicine, agriculture, food, and environmental sciences, LFA is gaining immense popularity across the globe.

Lateral Flow Assay Market Trends:
Due to the coronavirus disease (COVID-19) outbreak, there is a rise in the need for an alternative of sending patient samples to the laboratory. This, in confluence with the lack of extensive laboratory facilities or trained health workers to easily conduct polymerase chain reaction (PCR) tests, represents one of the key factors bolstering the growth of the market. LFA kits are convenient, smaller, portable, and can be controlled with minimal training. They act as a one-step assay that does not require washing steps, refrigeration, and pretreatment. They also faster test procedures that offer qualitative or semi-quantitative results, take a relatively short time for development, and allow the preparation of batches in advance. Besides this, there is an increase in the prevalence of infectious diseases that require new diagnostic methods for effective treatment. This, along with the significantly rising awareness programs to enhance the spread of infections, diagnosis, and prevention, is contributing to market growth. Furthermore, leading players are introducing novel signal enhancement techniques and improving quantification systems and simultaneous detection, which is creating a favorable market outlook.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global lateral flow assay market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technique, product, application and end user.

Breakup by Technique:

Sandwich Assays
Competitive Assays
Multiplex Detection Assays

Breakup by Product:

Kits and Reagents
Lateral Flow Readers
Digital/Mobile Readers
Benchtop Readers

Breakup by Application:

Clinical Testing
Infectious Disease Testing
Cardiac Marker Testing
Pregnancy and Fertility Testing
Cholesterol Testing/Lipid Profile
Drug Abuse Testing
Others
Veterinary Diagnostics
Food Safety and Environment Testing
Drug Development and Quality Testing

Breakup by End User:

Hospitals and Clinics
Diagnostic Laboratories
Home Care
Pharmaceutical and Biotechnology Companies
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Biomérieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Merck KGAA, Perkinelmer Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report
1. How big is the global lateral flow assay market?
2. What is the expected growth rate of the global lateral flow assay market during 2023-2028?
3. What are the key factors driving the global lateral flow assay market?
4. What has been the impact of COVID-19 on the global lateral flow assay market?
5. What is the breakup of the global lateral flow assay market based on the technique?
6. What is the breakup of the global lateral flow assay market based on the product?
7. What is the breakup of the global lateral flow assay market based on the application?
8. What is the breakup of the global lateral flow assay market based on the end user?
9. What are the key regions in the global lateral flow assay market?
10. Who are the key players/companies in the global lateral flow assay market?